Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,753 | 19,726 | 24,588 | 24,480 | 28,686 |
| Receivables | N/A | N/A | N/A | 229 | 213 |
| Other current assets | 0 | 895 | 0 | 394 | 0 |
| TOTAL | $18,378 | $20,621 | $24,904 | $25,103 | $29,509 |
| Non-Current Assets | |||||
| PPE Net | 338 | 380 | 481 | 604 | 755 |
| Intangibles | 38 | 39 | 40 | 41 | 41 |
| TOTAL | $376 | $419 | $521 | $645 | $796 |
| Total Assets | $18,754 | $21,040 | $25,425 | $25,748 | $30,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 346 | 435 | 172 | 374 | 641 |
| Accrued Expenses | 1,753 | 1,253 | 1,444 | 1,590 | 1,207 |
| TOTAL | $2,102 | $1,690 | $1,616 | $1,964 | $1,855 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 302 | 468 | 1,014 | 2,413 | 3,960 |
| TOTAL | $302 | $468 | $1,014 | $2,413 | $3,960 |
| Total Liabilities | $2,404 | $2,158 | $2,630 | $4,377 | $5,815 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,069 | 817 | N/A | 756 | 703 |
| Common Shares | 246 | 235 | 231 | 211 | 211 |
| Retained earnings | -238,602 | -234,246 | -229,559 | -227,273 | -224,068 |
| Other shareholders' equity | 19 | 19 | 19 | 19 | 19 |
| TOTAL | $16,350 | $18,882 | $22,795 | $21,371 | $24,490 |
| Total Liabilities And Equity | $18,754 | $21,040 | $25,425 | $25,748 | $30,305 |